• Cost-Effectiveness of Linaclotide Compared to Antidepressants in the Treatment of Irritable Bowel Syndrome with Constipation in Scotland

    Nov 1, 2013, 00:00

  • Evaluation of Telemedicine Program (Ithaca)- Innovation in the Treatment of Arterial Hypertension Increasing the Compliance and Adherence in the Second Year of Its Implementation (2011-2012)

    Nov 1, 2013, 00:00

  • Application of New French Guidelines for Economic Evaluations- A Cost-Effectiveness Analysis of Apixaban in Patients with Non-Valvular Atrial Fibrillation in France

    Nov 1, 2013, 00:00

  • An Analysis of EQ-5D Quality of Life Data for a Cost-Effectiveness Analysis of Ivabradine Plus Standard Care Versus Standard Care Alone in Chronic HF

    Nov 1, 2013, 00:00

  • The Measurement of Health-related Quality of Life- German Findings from the Multi-Instrument Comparison (MIC) Study

    Nov 1, 2013, 00:00

  • A Systematic Literature Review on the Epidemiology and Economic Burden of Anaemia Associated with Chronic Kidney Disease

    Nov 1, 2013, 00:00

  • Can Variation in Hospital Procedure Rates Identify Candidates for Health Technology Reassessment and Disinvestment?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Chile

    Nov 1, 2013, 00:00

  • Self- Assesment of Health Professionals’ Communication Skills with Patients

    Nov 1, 2013, 00:00

  • Differential Discouting- Capturing the Value of Living Longer and Better

    Nov 1, 2013, 00:00

  • Survival Analysis with Covariates in Combination with Multinomial Analysis to Parametrize Time to Event for Multi-State Models

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Education for Health Care Students in Bosnia and Herzegovina

    Nov 1, 2013, 00:00

  • Comparison Between Everolimus (Afinitor®) and Chemotherapy Agents (Capecitabine, Docetaxel and Doxorubicin) for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast Cancer

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Fixed-Dose Combination (FDC) of Vildagliptin/Metformin for the Treatment of Diabetes Mellitus Type 2 in Mexico

    Nov 1, 2013, 00:00

  • Influence of Patient-Reported Outcomes on HTA Reimbursement Decisions

    Nov 1, 2013, 00:00

  • Patterns of Disease Remission Among Patients with Rheumatoid Arthritis Receiving Their First Biologic in European Union

    Nov 1, 2013, 00:00

  • Clinical and Health Economic Evidence Requirements for Obtaining Health Insurance Coverage for Innovative Medical Devices in Germany

    Nov 1, 2013, 00:00

  • Evaluación De Costo-Efectividad De La Trabeculoplastia Láser Selectiva Como Primera Opción De Tratamiento En Glaucoma Primario De Ángulo Abierto En Colombia

    Nov 1, 2013, 00:00

  • Costo Del Automonitoreo Glucémico En Pacientes En Tratamiento Combinado Oral Y Con Insulina En Argentina

    Nov 1, 2013, 00:00

  • Total and Low-Density Lipoprotein Cholesterol Levels in High Risk Patients Treated with Atorvastatin Monotherapy in the United Kingdom

    Nov 1, 2013, 00:00

  • Prescription Patterns of Antihypertensive Agents in T2DM Patients Visiting Tertiary Care Centre in North India

    Nov 1, 2013, 00:00

  • Using Lower Cost, Lower Efficacy Interventions Can Improve Population Health Outcomes Under Budget Constraints

    Nov 1, 2013, 00:00

  • Carbon Cost-Effectiveness of Cocooning Immunization Against Pertussis in England and Wales- An Ecological Perspective

    Nov 1, 2013, 00:00

  • The Humanistic and Economic Burden of Venous Thromboembolism in Cancer Patients- A Systematic Review

    Nov 1, 2013, 00:00

  • Differential Resource Use and Costs Among Inpatients and Outpatients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • Mapping and Analysing Pharmaceutical Policy Settings Worldwide

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Childhood Rotavirus Vaccination in Germany

    Nov 1, 2013, 00:00

  • Custos Das Fraturas Osteoporóticas No Sistema Público De Saúde Brasileiro

    Nov 1, 2013, 00:00

  • Investigating Safety-Appraoch in Saudi Arabia Ministry of Health Hospitals

    Nov 1, 2013, 00:00

  • Supplementary Health Insurance in Turkey

    Nov 1, 2013, 00:00

  • Validity of Self-Reported Dose of Patients Using Wafarin in Clinical Practice

    Nov 1, 2013, 00:00

  • Level of Asthma Control and Health Care Utilization in Latin America

    Nov 1, 2013, 00:00

  • Meta-Analysis of Efficacy of Romiplostim for Treatment of Immune Idiopathic Thrombocytopenia

    Nov 1, 2013, 00:00

  • Assessing the Relationship Between the Diabetes Health Profile and Diabetes Specific Clinical Indicators- Case for Tailored Therapeutics

    Nov 1, 2013, 00:00

  • Chronic Patients Response to the Implementation of International Non-Proprietary Name (INN) Prescribing in Greece

    Nov 1, 2013, 00:00

  • Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial

    Nov 1, 2013, 00:00

  • Impact of Bariatric Surgery on Obese Patients Management and Related Costs- A French National Claims Database Analysis Over the Period 2005 -2011

    Nov 1, 2013, 00:00

  • The Growing Role of Qualitative Interviews in Health Outcomes Research

    Nov 1, 2013, 00:00

  • The Burden of Disease Attributable to Physical Inactivity in the Austrian Region of Burgenland

    Nov 1, 2013, 00:00

  • Relative Efficacy and Acceptability of Vortioxetine Versus Marketed Antidepressants

    Nov 1, 2013, 00:00

  • Patient Functioning in Generalized Anxiety Disorder Subjects with Partial Response to Prior SSRI Treatment- The Effect of Adjunctive Therapy with Pregabalin in Daily Medical Practice

    Nov 1, 2013, 00:00

  • Utilization of the Hungarian Publicly Financed Health Care System by Third (Non EU) Country Citizens

    Nov 1, 2013, 00:00

  • The Hybrid Purchaser-Provider Split in England- Should Europe Follow Suit?

    Nov 1, 2013, 00:00

  • A Comparison of Methodologies for Estimating Survival in Patients Treated with Second-generation Tyrosine-kinase Inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)

    Nov 1, 2013, 00:00

  • A Critical Appraisal of Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening- Making Appropriate Comparisons and Usefully Interpreting Results

    Nov 1, 2013, 00:00

  • Attitudes, Beliefs and Behaviours of General Practitioners Regarding Vaccination- Development of a Characterisation Tool – Qualitative Steps

    Nov 1, 2013, 00:00

  • Cost Analysis of Pulmonary Arterial Hypertension in a Tertiary Care Setting in Mexico City

    Nov 1, 2013, 00:00

  • Dynamics of Quality of Life in Children with Cystic Fibrosis Aged 5-16 Years

    Nov 1, 2013, 00:00

  • Treatment Costs of Ischemic Stroke Prevention and Management in Patients with Atrial Fibrillation (AF) in Latin America- Argentina, Brazil, Chile, and Venezuela

    Nov 1, 2013, 00:00

  • Health Outcomes of Female Anabolic-Androgenic Steroid Users

    Nov 1, 2013, 00:00

  • Cost of Treatment After Renal Transplantation in Iran- Should Government Continue Paying for New Expensive Immunosuppressive Drugs?

    Nov 1, 2013, 00:00

  • Economic Evaluation of Tips Compared to Large Volume Paracentesis in Patients with Refractory Ascites

    Nov 1, 2013, 00:00

  • The Impact of Indication Extensions on Pharmaceutical Prices

    Nov 1, 2013, 00:00

  • Fatores Associados À Compra De Medicamentos Em Brasília- Uma Análise Econométrica Com Dados Transversais De Base Populacional

    Nov 1, 2013, 00:00

  • Cost-Effectiveness and Cost-Utility Analysis of Belimumab for the Treatment of Patients with Systemic Lupus Erythematosus in Portugal

    Nov 1, 2013, 00:00

  • Following the Western HTA Model in Latin America- A Self-Fulfilling Prophecy?

    Nov 1, 2013, 00:00

  • Pivotal Studies of Orphan Medicinal Products – an Analysis of Quality of Clinical Evidence

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Ceftaroline Versus Linezolid or Vancomycin on the Top of Standard Therapy in the Treatment of Complicated Skin and Soft Tissues Infections in Russian Federation

    Nov 1, 2013, 00:00

  • Resource Utilization and Costs for Patients with Inflammatory Bowel Diseases in Italy- A Population-Based Assessment

    Nov 1, 2013, 00:00

  • Systematic Literature Review in Moderate to Severe Ulcerative Colitis

    Nov 1, 2013, 00:00

  • A Time-Motion Comparison of Itemized Treatment Costs in First Versus Subsequent Cycles of in Vitro Fertilization (IVF)- Treatments Can Optimized for Improving Outcomes While Increasing Patient Volumes in Cost-Constrained Regions

    Nov 1, 2013, 00:00

  • The Influence of Improved Adherence and Persistence in Chronic Obstructive Pulmonary Disease (COPD) Costs- Systematic Review of the Literature

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad De Intervenciones Para El Manejo Del Trastorno Depresivo Mayor (TDM) En Pacientes Con Virus De La Inmunodeficiencia Humana (VIH+) Que Inician Tratamiento Antirretroviral De Gran Actividad (TARGA)

    Nov 1, 2013, 00:00

  • A Retrospective Study Comparing Compliance, Persistence, and Blood Pressure Control Between Free-Drug and Single-Pill Combination Therapies in Korean Hypertensive Patients

    Nov 1, 2013, 00:00

  • Explaining the Increased Health Care Expenditures Among Individuals with Co-Occurring Chronic Obstructive Pulmonary Disease and Gastroesophageal Reflux Disease- A Cost-Decomposition Analysis

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Mexico

    Nov 1, 2013, 00:00

  • Direct-To-Patient Contact and Proactive Pharmacovigilance System- A Case Study

    Nov 1, 2013, 00:00

  • Confirmatory Factor Analysis and Evaluation of Clinically Important Differences in Menopause-Specific Quality of Life Associated with Bazedoxifene/Conjugated Estrogens in a Vulvar/Vaginal Atrophy Population

    Nov 1, 2013, 00:00

  • Análisis De Costos Mediante Un Modelo Lineal Generalizado De Pacientes Mexicanos Con Sindrome De West

    Nov 1, 2013, 00:00

  • Venous Thromboembolism in Gynae-Oncology Patients Post Surgery – Is Tinzaparin Prophylaxis an Effective Anticoagulant?

    Nov 1, 2013, 00:00

  • Assessment of the Perception and Practices with Respect to Antibiotic Usage in Public Through Social Media

    Nov 1, 2013, 00:00

  • The Economic Footprint of the Greek Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • A Budgetary Impact Analysis Model for Everolimus in the Treatment of ER+ HER2- Metastatic Breast Cancer in England and Wales

    Nov 1, 2013, 00:00

  • Prescribing Patterns of Parkinson’s Disease

    Nov 1, 2013, 00:00

  • Análise Comparativa Dos Anticoncepcionais Orais Com Diferentes Concentraçoes De Etinilestradiol Em Relação Aos Perfis De Eficácia E De Adesão

    Nov 1, 2013, 00:00

  • Squaring the Circle- Innovative Contracting to Achieve Market Access for Innovative Products

    Nov 1, 2013, 00:00

  • Adherence to Treatment and Persistency in Patients Treated with VKA in France, Italy, Germany, Spain and the United Kingdom

    Nov 1, 2013, 00:00

  • Using a Cause-Of-Death-Based Mortality Model to Identify the Individuals Who Would Benefit Most from Primary Prevention with Statins

    Nov 1, 2013, 00:00

  • Impact of Patient Weight Trajectory on Cost-Effectiveness of Treatments of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • Evaluation of the Policies Implemented to Monitor Prescription and Reduce Pharmaceutical Expenditure at the University General Hospital of Patras, Greece

    Nov 1, 2013, 00:00

  • Therapy Sequences in Multiple Myeloma – A Clinical Model Study in Regards of a German Cost Context

    Nov 1, 2013, 00:00

  • Cost of Illness of Neuropathic Pain in Spain in 2012 from a Societal Perspective

    Nov 1, 2013, 00:00

  • Three-Year Health Care Expenditures in Diabetic Patients Receiving Rapid-Acting Insulin Analogues Versus Those on Human Regular Insulin

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Benefits of Citicoline in the Treatment of Acute Ischemic Stroke in Russia

    Nov 1, 2013, 00:00

  • Pertussis in Brazilian Children- Mortality, Length of Stay, and Costs in Hospitalized Patients

    Nov 1, 2013, 00:00

  • A Cost-Utility Analysis of Everolimus Plus Exemestane for the Treatment of ER+ HER2- Metastatic Breast Cancer in the United Kingdom

    Nov 1, 2013, 00:00

  • A Systematic Review of Antidepressants in Irritable Bowel Syndrome- A Qualitative Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis in Institutional Market in Ecuador

    Nov 1, 2013, 00:00

  • Chronic Patients’ Access to Physicians Services in Times of Economic Crisis

    Nov 1, 2013, 00:00

  • The Use of European Electronic Health Records to Investigate Cancer Treatment Pathways

    Nov 1, 2013, 00:00

  • Cost-Utility of Active Surveillance for the Treatment of Localized Prostate Cancer in the Context of the German Health Care System

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Caspofungin Versus Voriconazole for Empiric Therapy in Turkey

    Nov 1, 2013, 00:00

  • The Costs of Surgical Aortic Valve Replacement in France

    Nov 1, 2013, 00:00

  • The Relative Economic Value of Ipilumumab in Colombia

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis- A Scottish Perspective

    Nov 1, 2013, 00:00

  • Measuring Treatment Effects on Rare Events Using Meta-Analysis- An Assessment of Existing Methods

    Nov 1, 2013, 00:00

  • Health State in Patients with Atrial Fibrillation on New Oral Anticoagulants as Assessed with the New EQ-5D-5L Questionnaire- Prefer in AF Registry

    Nov 1, 2013, 00:00

  • Epidemiological and Economic Impact of Chronic Kidney Disease in Patients with Hypertension and Diabetes in Colombia

    Nov 1, 2013, 00:00

  • Appropriate Evidence Sources for Populating Decision Analytic Models Within Health Technology Assessment (HTA)- A Systematic Review of HTA Manuals and Health Economic Guidelines

    Nov 1, 2013, 00:00

  • Quality Improvement Initiatives for Patients on Warfarin in Primary Care

    Nov 1, 2013, 00:00

  • Comparing the Value of Different HTA Decision Making Process- Evaluating the Evaluators

    Nov 1, 2013, 00:00

  • Indirect and Direct Savings Resulted from Parallel Trade of Pharmaceuticals in Poland – Results of Valuation Sales Data from Public Pharmacies

    Nov 1, 2013, 00:00

  • Clinical Effectiveness Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions

    Nov 1, 2013, 00:00

  • How Does Prescription of Generic Drugs Spread Out?- Data Mining and Visualization by Using Prescription Data Form Acute Care Hospitals Nationwide

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Botulinum Toxin a Therapy for Upper Limb Spasticity in the United Kingdom

    Nov 1, 2013, 00:00

  • Screening Strategies for Heart Failure in Patients with Type 2 Diabetes- Assessing Cost-Effectiveness in Those Aged 60 Years or Over

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Atorvastatin Compared to Simvastatin in the Prevention of Cardiovascular Diseases in the Czech Republic

    Nov 1, 2013, 00:00

  • Network Meta-Analysis with Fractional Polynomials for Repeated Trough FEV1 Measures in COPD- Aclidinium Bromide 400 μG Bid Versus Tiotropium 18 μG QD

    Nov 1, 2013, 00:00

  • Do Nice Evidence Review Groups (ERG) Focus on Different Aspects of Manufacturer Submissions in Oncology?

    Nov 1, 2013, 00:00

  • Can We Use the EQ-5D Only for Assessing the Quality of Life of Patients with Osteoporosis?

    Nov 1, 2013, 00:00

  • Comparative Study of the Cost-Effectiveness of Trastuzumab in the Treatment of Breast Cancer in Different Countries

    Nov 1, 2013, 00:00

  • ePRO Migration and Usability Testing of Patient-Reported Outcome (PRO) Measures

    Nov 1, 2013, 00:00

  • Relationship Between Body Mass Index and Health Care Costs by Place of Service in Employed Adults

    Nov 1, 2013, 00:00

  • Number of Submissions Needed to Reach a Positive Reimbursement Decision from SMC, CADTH, and PBAC

    Nov 1, 2013, 00:00

  • Bisphosphonates-Associated Osteonecrosis of Jaw in Cancer Patients- A Meta-Analysis

    Nov 1, 2013, 00:00

  • Impacto Financiero Del Tratamiento Farmacológico En Pacientes Adultos Con Enfermedad De Gaucher Tipo 1 En México

    Nov 1, 2013, 00:00

  • A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer

    Nov 1, 2013, 00:00

  • Individually Tailored Elastic Compression Therapy for the Prevention of Post Thrombotic Syndrome

    Nov 1, 2013, 00:00

  • Systematic Literature Review of Economic Burden of Chronic Plaque Psoriasis

    Nov 1, 2013, 00:00

  • Treating Psoriatic Arthritis with Biological Disease Modifying Antirheumatic Drugs- Systematic Review and Meta-Analysis to Evaluate Efficacy and Safety

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Health Care Resource Utilization

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintena ...

    Nov 1, 2013, 00:00

  • Costo E Impacto Presupuestal Del Tratamiento Del Cáncer De Púlmon De Celulas No Pequeñas Del Tipo Adenocarcinoma Con Grado Ecog 0,1,2 En Estadio Iv Con Mutación + (EGFR O ALK) Con Terapias Blanco En México

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of School-Based Health Promotion in Canada- A Life-Course Modeling Approach

    Nov 1, 2013, 00:00

  • Varicella Vaccine as Post-Exposure Prophylaxis – a Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Do Policy Measures Impact on Cost Consciousness of Health Care Professionals?

    Nov 1, 2013, 00:00

  • First Russian Type 2 Diabetes Mellitus Simulation Model with Discrete Events Modeling. Health-Economic Analysis

    Nov 1, 2013, 00:00

  • Design of Lupus Impact Tracker (LIT) Validation Study in Five European Clinical Practice Settings

    Nov 1, 2013, 00:00

  • Reliability and Validity of the Pediatric Quality of Life Inventory Generic Core Scales for Dutch Children with Functional Constipation

    Nov 1, 2013, 00:00

  • Agranulocytosis Detection Outcome By Clozapine Treatment (Adoc Study) in Psychiatry- A Cost-Effectiveness Study

    Nov 1, 2013, 00:00

  • Covering the PASS- Development of Protocol Template Language (PTL) for Data Collection and Data Management (DM) in Post-Authorization Safety Studies (PASS)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analyses of Natalizumab for 2nd Line Versus Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients in Brazil

    Nov 1, 2013, 00:00

  • Real World Incidence of Type 2 Diabetes (T2D) Complications Leading to Hospitalization in Fran The Recode Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

    Nov 1, 2013, 00:00

  • Qualidade De Vida Dos Pacientes Que Utilizam Medicamentos Anti-TNF Para O Tratamento De Doenças Reumáticas No Sistema Único De Saúde Em Minas Gerais, Brasil

    Nov 1, 2013, 00:00

  • Differences in Medical Cost and Survival Between Trial and Non-Trial Patients with Acute Myeloid Leukaemia – A UK Population-Based Propensity Analysis

    Nov 1, 2013, 00:00

  • A Mixed Treatment Comparison (MTC) to Compare Progression Free Survival (PFS) Associated with Different Chemotherapy Regimens for Platinum-Sensitive or Partially Platinum-Sensitive Recurrent Advanced Ovarian Cancer

    Nov 1, 2013, 00:00

  • Health Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease in North India

    Nov 1, 2013, 00:00

  • Burden of Varicella in Latin America- A Systematic Review and Critical Analysis

    Nov 1, 2013, 00:00

  • Exploring Dependence on Others in Alzheimer’s Disease

    Nov 1, 2013, 00:00

  • Description of Treatment Pathways in Chronic Diseases Using Large General Practitioner Longitudinal Data- The Example of Pharmaco-Therapy in Parkinson’s Disease in the United Kingdom

    Nov 1, 2013, 00:00

  • Disease Burden Among Patients with Psoriatic Arthritis Who Have Experienced First Line Tumor Necrosis Factor Inhibitor Regimen Failure in the European Union

    Nov 1, 2013, 00:00

  • The Budget Impact of Introducing Bg-12 (Dimethyl Fumarate) for Treatment of Relapse-Remitting Multiple Sclerosis (RRMS) in Canada

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Cinacalcet Chronic Kidney Disease Patients on Dialysis with Secondary Hyperparathyroidism in Brazilian Public Health Care System (SUS)

    Nov 1, 2013, 00:00

  • Treatments for EGFR Mutation Positive NSCLC – A Network Meta-Analysis

    Nov 1, 2013, 00:00

  • A Price Comparison Study of Recent Drugs in EU5, 2008-2012

    Nov 1, 2013, 00:00

  • 4-Valent Vaccine Patients – Statistical Assessment of a New Estimation Methodology

    Nov 1, 2013, 00:00

  • Cost Minimization Analysis of the Dienogest Use in Patients with Endometris under Brazilian Public and Private Perspective

    Nov 1, 2013, 00:00

  • Guidance for Partnership Working Between CatSalut and the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Health State (QALY) Values for Multiple Sclerosis- A Report Using Data from the United Kingdom South West Impact of Multiple Sclerosis (SWIMS) Study

    Nov 1, 2013, 00:00

  • Assessment of Generic Drug Policy Implementation by Measuring Persistence with Antihypertensive Drug Therapies After Patent Expiry

    Nov 1, 2013, 00:00

  • Iceberg Phenomenon of Heart Failure in Hospitalized Patients- A Multicentric Cross Sectional Study

    Nov 1, 2013, 00:00

  • Measuring Patient-relevant Treatment Benefit in Dermatology – Development and Validation of the Short Questionnaire “Patient Benefit Index 2.0”

    Nov 1, 2013, 00:00

  • A Cost Analysis of Medication for Patients with Type 2 Diabetes Mellitus (T2DM) – How This Varies According to Body Mass Index (BMI) Status, Age, Gender and Co-Morbidity

    Nov 1, 2013, 00:00

  • Long-Term Fiscal Implications of Funding Assisted Reproductive Therapies- A Generational Accounting Model for Spain

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Assessment of Different Tactics of COPD Treatment in Russia

    Nov 1, 2013, 00:00

  • Comparison of Treatment Satisfaction in Patients with Asthma Taking Leukotriene Modifiers Verus Those Taking Inhaled Corticosteroids

    Nov 1, 2013, 00:00

  • Costs and Effectiveness of Non-Smoking Clinic

    Nov 1, 2013, 00:00

  • Cost-Comparison Between Different Treatment Regimens in Diabetes Mellitus in Germany Based on Long Acting Insulins

    Nov 1, 2013, 00:00

  • Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erithematosus in the Italian Setting- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Comparison of Markov and Discrete Event Simulation Modeling Techniques with Application to Cost Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Custo-Efetividade Do Tratamento Para Osteoporose Na Pos-Menopausa No Brasil

    Nov 1, 2013, 00:00

  • Burden of Dose Escalation with Biologics in Rheumatoid Arthritis- A Review of Frequency and Costs

    Nov 1, 2013, 00:00

  • Direct Health Care Costs of Patients Switching Biologic Therapies in Chronic Plaque Psoriasis

    Nov 1, 2013, 00:00

  • The French Public Health Care System- An Original Way for Cost Saving

    Nov 1, 2013, 00:00

  • Methodology of an Observational Study to Evaluate the Care Map of Women with Postmenopausal Osteoporosis (PMO) in Switzerland

    Nov 1, 2013, 00:00

  • Short Run Dynamics of Inadequate Pain Relief (IPR)- Evidence from a European Multinational Survey of Real World Therapies (SORT)

    Nov 1, 2013, 00:00

  • Effectiveness and Cost Analysis of the Smoking Cessation Program in the Public Health System in Brazil

    Nov 1, 2013, 00:00

  • Multi-Criteria Benefit-Risk Assessment of Biological Agents in the Treatment of Moderate to Severe Psoriais- A Stochastical Approach

    Nov 1, 2013, 00:00

  • Item Refinement and Psychometric Testing of a Novel Survey for Evaluating Patient Perception and Preference for Haemophilia a Treatment

    Nov 1, 2013, 00:00

  • Costs and Outcomes Associated with Multidrug Resistant Staphylococcus Aureus Bacteremia

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Metastatic Colorectal Cancer (mCRC)- A Utilities Study in the United Kingdom and the Netherlands

    Nov 1, 2013, 00:00

  • Exploring the Feasibility of the Instrument Used in Determination of Willingness-To-Pay Per Quality-Adjusted Life-Year in Malaysia

    Nov 1, 2013, 00:00

  • Clinical Outcomes Assessments in Schizophrenia- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • The Relationship Between Treatment Satisfaction and Adherence in COPD Patients in 5 Countries

    Nov 1, 2013, 00:00

  • Patient Reported Outcomes with Multiple Sclerosis in Slovakia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in Japan

    Nov 1, 2013, 00:00

  • Clinical and Economic Analysis of Mometasone Furoate Nasal Spray in the Treatment of Rhinosinusitis in Mexico

    Nov 1, 2013, 00:00

  • Relationship Between Modelling Approach and Reported Outcomes- Case Studies of Models for the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • Systematic Review on the Impacts of Strict Pharmaceutical Price Controls

    Nov 1, 2013, 00:00

  • Estimación De La Prevalencia De Artritis Reumatoide En México

    Nov 1, 2013, 00:00

  • Recruting Physicians for Health Outcome and Post-Approval Studies- Benefits of a Managed Physician Panel

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of First-Line Treatment of Advanced Metastatic Non Small Cell Lung Cancer- A Systematic Review of Economic Models

    Nov 1, 2013, 00:00

  • Influence of One Week Education Program on the Knowledge and Approach of Pharmacy Students Towards Diabetes Mellitus

    Nov 1, 2013, 00:00

  • Comparative Cost-Consequence Analysis of the Bivalent and Quadrivalent Vaccines Against HPV in Spain

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Posaconazole Versus Fluconazole for Prevention of Invasive Fungal Infections in Patients with Graft-Versus-Host Disease in Sweden

    Nov 1, 2013, 00:00

  • Effect of Ivabradine on Thai Chronic Stable Angina Pectoris Patients

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Enzyme Replacement Therapy (ERT) with Alglucosidase Alfa in Classic-Infantile Patients with Pompe Disease

    Nov 1, 2013, 00:00

  • Comparative Economic Analysis of Retreatment Strategies for HCV Genotype 1 Patients in Russia

    Nov 1, 2013, 00:00

  • Standardized Tool for Measurement of Health Services Costs and Utilization in a Sample with Mental Disorders- Translation, Cultural Adaptation and Interrater Reliability of the Client Sociodemografic and Service Receipt Inventory Brazilian ...

    Nov 1, 2013, 00:00

  • Inpatient Hospital Costs of Febrile Neutropenia (FN) as a Consequence of Chemotherapy (CHT) for Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) in Switzerland

    Nov 1, 2013, 00:00

  • A Cost-Analysis of Stereotactic Radiotherapy in Lung Cancer

    Nov 1, 2013, 00:00

  • Difference in Interdialytic Intervals Leading to Hospital Admission and Mortality in Hemodialysis Patients

    Nov 1, 2013, 00:00

  • Likelihood of Use and Perception Towards Biosimilars in Rheumatoid Arthritis Arena- Survey of Rheumatologists in European Union, Brazil, Japan and China

    Nov 1, 2013, 00:00

  • Compliance Protects Against Fracture in Women with Postmenopausal Osteoporosis in Hungary

    Nov 1, 2013, 00:00

  • Impacto En La Productividad Laboral De Una Cohorte De Pacientes Con Artritis Reumatoide Tratados Con Etanercept (Enbrel®) En Colombia

    Nov 1, 2013, 00:00

  • Croatia’s EU Accession in the Context of International Reference Pricing- What Will Be the Wider Impact for Pricing and Reimbursement?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany

    Nov 1, 2013, 00:00

  • Economic Impact of Improving the Accuracy of Blood Glucose Self-Monitoring on the Spanish Health Service

    Nov 1, 2013, 00:00

  • Development of the Schizophrenia Caregiver Questionnaire- Modification of the Zarit Burden Interview Informed by Qualitative Insights

    Nov 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Isolated and Concomitant Aortic Valve Replacements in Germany

    Nov 1, 2013, 00:00

  • Analysis of the Pricing and Market Access Landscape of Orphan Drugs in Latin America

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Children and Young People with Chronic Hepatitis C from the Perspective of the NHS in England and Wales

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Aspects of Actovegin and Solcoseryl in the Treatment of Russian Patients with Acute Cerebrovascular Accidents

    Nov 1, 2013, 00:00

  • The Burden of Resistant Hypertension in 5 European Countries

    Nov 1, 2013, 00:00

  • The Disease Burden of Influenza in Germany

    Nov 1, 2013, 00:00

  • Demineralised Bone Matrix (DBM) Versus Iliac Crest Bone Graft (ICBG) for Lumbar Spinal Fusion Procedures in the United Kingdom; A Budget-Impact Analysis

    Nov 1, 2013, 00:00

  • Effectiveness of Different Dosage Regimen of Pralidoxime in Organophosphorus Poisoning in Tertiary Care Hospital

    Nov 1, 2013, 00:00

  • Medication Use Patterns and Adherence After Initiating Antipsychotics Treatment for Patients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • Evaluating Different Modes of Radiotherapy Based on a Patient-Level Simulation Model

    Nov 1, 2013, 00:00

  • The Impact of Smoking on Hospital Costs in Times of Crisis; An Additional Burden to the Vulnerable Greek Health Care System

    Nov 1, 2013, 00:00

  • Resource Consumption Evaluation Associated with Rituximab Administration in Portugal

    Nov 1, 2013, 00:00

  • A Choice of Business for the Pharmaceutical Industry “Seguro Popular” in Mexico

    Nov 1, 2013, 00:00

  • Counting the Cost of Meningococcal Disease in France

    Nov 1, 2013, 00:00

  • Quality Criteria for the Development of Implant Registries

    Nov 1, 2013, 00:00

  • Conceptual and Practical Considerations when Dealing with Missing Utility Data in Longitudinal Trials, and Subsequent Use in Cost-Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Identification of the Treatment Pathway of Metastatic Castrate-Resistant Prostate Cancer in Scotland- A Chart Review

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Type 2 Diabetes in Poland- Comparison with General Population Using EQ-5D Questionnaire

    Nov 1, 2013, 00:00

  • Meta-Analysis of Quality of Life in Coronary Heart Disease

    Nov 1, 2013, 00:00

  • Relevance of a National Forecast Growth Rate, as a Regulation Tool of the Expensive Hospital Drug Spending, in France

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Early Versus Delayed Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy in Adults Aged 40+ in France

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also known as C. Difficile-Associated Diarrhoea (CDAD) in Ireland

    Nov 1, 2013, 00:00

  • Evaluation of the Burden of Illness of Colorectal Cancer Among Veteran Patients in the United States

    Nov 1, 2013, 00:00

  • Economic Analysis of Use of Harmonic Devices in Inpatient Laparoscopic Cholecystectomy in the United States

    Nov 1, 2013, 00:00

  • Generating and Maintaining Momentum in Post-Authorisation Studies

    Nov 1, 2013, 00:00

  • Mapping from PDQ-39 and PDQ-8 Onto EQ-5D Utility Index in Patients with Parkinson’s Disease- Extended Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Boceprevir Add-On Treatment of Hepatitis C Virus Genotype 1 Patients in Denmark

    Nov 1, 2013, 00:00

  • A Systematic Review of Economic Evidence in Hepatitis C- An Overview of Cost, Utility and Cost-Effectiveness Data

    Nov 1, 2013, 00:00

  • Desigualdad En Salud Relativa Al Ingreso En Chile- Análisis De Descomposición Del Índice De Concentración En Hipertensión, Diabetes Y Depresión

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Systematic Testing for Lynch Syndrome in Patients Newly Diagnosed with Colorectal Cancer in the United Kingdom

    Nov 1, 2013, 00:00

  • Level and Factors Impacting the Patient Dissatisfaction in the Primary Care Visits Based on the Cross-Section Measurement – a Prospective Finnish Study

    Nov 1, 2013, 00:00

  • How to Select the Right Cost-Effectiveness Model? A Systematic Review and Stepwise Approach for Transferring an Existing Health Economic Model for Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Long-Term Prolonged-Release Fampridine Treatment and Health-Related Quality of Life Outcomes- Interim Results of the Enable Study

    Nov 1, 2013, 00:00

  • Public Health Impact and Cost Effectiveness of Pneumococcal Vaccination for Adults in Puerto Rico

    Nov 1, 2013, 00:00

  • Canadian Private Payers’ Perceptions and Expectations of Submission Requests for Drug Reimbursement Submitted by the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Modelling Uncertain Future Events in Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • How Does Hospitalization Impact Insulin Treatment in Diabetes Mellitus? Results of a Retrospective German Database Analysis

    Nov 1, 2013, 00:00

  • Application of Copulas in Economic Evaluation

    Nov 1, 2013, 00:00

  • How Complex Is the Competition in Regulated Pharmaceutical Markets?

    Nov 1, 2013, 00:00

  • Economical Losses Due to Disablementparents Carring for Children with Oncohematological Diseases

    Nov 1, 2013, 00:00

  • Parameter Uncertainty in Value Based Multi Criteria Decision Analysis- A Systematic Review of Methods

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Linezolid Versus Vancomycin in the Treatment of Ventilator Associated Pneumonia in Jamaica

    Nov 1, 2013, 00:00

  • G-Ba Assessments of Oncology Trials- Is Increased Overall Survival a “Must Have”?

    Nov 1, 2013, 00:00

  • Update of the Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID)- Inclusion of E-PRO Information

    Nov 1, 2013, 00:00

  • Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • Telemonitoring After Discharge from Hospital with Heart Failure – Cost-Effectiveness Modelling of Alternative Service Designs

    Nov 1, 2013, 00:00

  • Impact of Autism Spectrum Disorders on the Family – A National Perspective

    Nov 1, 2013, 00:00

  • Using Structural Equation Modeling to Detect Response Shift and True Change in Health-Related Quality-Of-Life Scores of Breast Cancer Patients After Surgery

    Nov 1, 2013, 00:00

  • A Quebec Economic Evaluation for 36 Months of Ranibizumab for the Treatment of Diabetic Macular Edema

    Nov 1, 2013, 00:00

  • Beta-Thalassemia Patients Survey on Deferrization Therapy

    Nov 1, 2013, 00:00

  • What Factors Predict the Decision to Treat Acute Coronary Syndrome Invasively? Evidence from Clinical Practice

    Nov 1, 2013, 00:00

  • Potentially Inappropriate Prescribing (PIP) and Its Association with Instrumental Activities of Daily Living (IADL) Impairment in Older People

    Nov 1, 2013, 00:00

  • Paediatric Tuberculosis - Costs to the Irish Health Care Payer

    Nov 1, 2013, 00:00

  • Obtaining Optimal Personalized Surveillance Strategies for Patients with Screen-Detected Colorectal Adenomas Using Discrete Event Simulation

    Nov 1, 2013, 00:00

  • Differential Item Functioning in a Satisfaction Item Bank

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Screening Y Tratamiento De Hipoacusia Bilateral En Recién Nacidos (Rn) En Chile

    Nov 1, 2013, 00:00

  • Hepatocellular Carcinoma- An Epidemiological and Management Survey-Based Analysis in Italy

    Nov 1, 2013, 00:00

  • Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung Cancer

    Nov 1, 2013, 00:00

  • Estimating and Modeling Long Term Survival in Lung Cancer Using Mixture Parametric Models

    Nov 1, 2013, 00:00

  • Adherence Rates for Intravenous Chemotherapy Regimens to Treat Colon Cancer

    Nov 1, 2013, 00:00

  • Treatment Patterns Among Type 2 Diabetes Mellitus Patients in Dubai

    Nov 1, 2013, 00:00

  • Spectacle Independence and Vision-Related Quality of Life in Cataract Surgery Patients Following Implantation of a Multifocal Intraocular Lens

    Nov 1, 2013, 00:00

  • Assesment of the Cost of Biological Therapy in Rheumatic Diseases- Economic Impact of Dosage Modification in Clinical Practice

    Nov 1, 2013, 00:00

  • Systematic Review on the Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Incidence/Prevalence, Risk Factors and Complications of Type 2 Diabetes Mellitus in Indian Patients- A Systematic Review and Meta-Analysis

    Nov 1, 2013, 00:00

  • EMA Approval of Drugs on the Basis of Pivotal Non-Comparative Phase II Trial Data

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Biological Disease-Modifying Antirheumatic Drugs in the Treatment of Russian Patients with Rheumatoid Arthritis Who Failed Previous Anti-Tnf-Alfa Therapy

    Nov 1, 2013, 00:00

  • Is Hospitalized Multi-Morbidity in Adults Determining Costs of Re-Admission? Evidence from a Multicentric Cross Sectional Study in Argentina

    Nov 1, 2013, 00:00

  • The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia- A Transmission Dynamic Model-Based Evaluation

    Nov 1, 2013, 00:00

  • Table of Contents

    Nov 1, 2013, 00:00

  • Recent Trends in Incidence and Demographics of Pediatric Meningococcal Disease in the United States

    Nov 1, 2013, 00:00

  • Side-Effects of Antiepileptic Drugs- The Economic Burden

    Nov 1, 2013, 00:00

  • Accessibility of Orphan Drugs in France, United Kingdom and Germany- Different Approaches with Regard to HTA and Prices

    Nov 1, 2013, 00:00

  • The Importance of Patient Reported Outcomes in Reimbursement of Orphan Products in Europe

    Nov 1, 2013, 00:00

  • Easing Decision-Making by Expanding Methods of Multiple Treatment Comparison Meta-Analysis – Incorporating Non-Comparative Studies Via Informative Priors

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of the Oral Hypoglycemic Agents in the Treatment of Type 2 Diabetes Mellitus Patients in the Russian Federation

    Nov 1, 2013, 00:00

  • A Lesson Learnt from Avastin®- - Bevacizumab Induced Hypertension as a Predictive Biomarker of Patient Response in Overcoming Regulatory and Health Technology Assessment (HTA) Hurdles

    Nov 1, 2013, 00:00

  • Evaluation of the Cost-Effectiveness of the Capsaicin Patch Qutenzatm for the Treatment of Peripheral Neuropathic Pain in the United Kingdom

    Nov 1, 2013, 00:00

  • Study of Antibiotic Consumption Pattern in Hospital Acquired Pneumonia

    Nov 1, 2013, 00:00

  • The Cost-Utility of Insulin Degludec Compared with Current Standard of Care in the Management of Type One and Type Two Diabetes Mellitus in Belgium

    Nov 1, 2013, 00:00

  • Cost and Length of Stay Associated with Vancomycin-Induced Nephrotoxicity

    Nov 1, 2013, 00:00

  • Assessing the Impact of Organized Screening for Abdominal Aorta Aneurysms in Austria – Following Eunethta Core Information

    Nov 1, 2013, 00:00

  • Clinical Outcomes of Patients with Major Depressive Disorder Treated with Either Duloxetine or Selective Serotonin Reuptake Inhibitors in Mexico

    Nov 1, 2013, 00:00

  • Management of Obese Women During Pregnancy Across Europe According to Clinical Practice Guidelines

    Nov 1, 2013, 00:00

  • Cost Analysis of Anti-Migraine Prescribing Using a Claims Database

    Nov 1, 2013, 00:00

  • Quadrivalent Versus Trivalent Influenza Vaccine- Is It Good Value for Money?

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Triple Therapy Versus Dual Therapy for Chronic Hepatitis C Virus Infection in Kazakhstan

    Nov 1, 2013, 00:00

  • Evolution of Oral Anticancer Treatments Use in France from 2004 – 2012- Re-Actor Study (Retrospective Analysis of Cancer Treatments Given Orally)

    Nov 1, 2013, 00:00

  • Trends in Reimbursement Decisions in Ireland- An Analysis of the NCPE Database from an Industry Perspective

    Nov 1, 2013, 00:00

  • Economic Analysis of the Prevention of Medical Sharps Injuries with Safety-Engineered Devices- A Systematic Review

    Nov 1, 2013, 00:00

  • Economic Evaluation of an Urine Closed Collection System Versus a Traditional Open Device in Non-Pregnant Women

    Nov 1, 2013, 00:00

  • Lower Short-Term Health Care Cost with the Accu-Chek Aviva Expert System in Multiple Daily Insulin Injection (MDI) Treated Diabetes Patients - Learnings from the Automated Bolus Advisor Control and Usability Study (ABACUS)

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Treatment of Spasticity with Botulinum Toxin Type A

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated with Docetaxel from the Perspective of the Brazilian Private Health Care System

    Nov 1, 2013, 00:00

  • Validation of Surrogate Endpoints in Advanced Solid Tumours- Systematic Review of Statistical Methods, Results, and Implications for Policy Makers

    Nov 1, 2013, 00:00

  • Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly- A Discrete Choice Study

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad De Everolimus Más Exemestano Para Pacientes Con Cáncer De Mama Avanzado Con Receptores Hormonales Positivos (RE+), HER2–, Que Fallaron a Los Inhibidores De Aromatasa No Esteroideos (IANES) En México

    Nov 1, 2013, 00:00

  • Economic Burden of Venous Thromboemoblism Across Patient Populations- A Literature Review

    Nov 1, 2013, 00:00

  • Perception of Country-Specific Health Care Reform and Consideration of Real World Evidence in Routine Practi Survey of Oncologists in European Union, United States, China and Brazil

    Nov 1, 2013, 00:00

  • Economic Evidence of Surgical Procedures in Cancer- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • The First Experiences with Reassessments and Appraisals of Conditionally Approved Expensive and Orphan Drugs in the Netherlands (2006-2013)

    Nov 1, 2013, 00:00

  • Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of a 13-Valent Conjugate Pneumococcal Vaccination Program in COPD Patients Aged ≥50 Years in Spain- Preliminary Results

    Nov 1, 2013, 00:00

  • Comparing Virtual Colonography with Conventional Colonoscopy for Colorectal Cancer Screening- What are the Drivers of Cost-effectiveness?

    Nov 1, 2013, 00:00

  • Access to Medicines Index- Measuring How Well Countries Provide Access to Medicines

    Nov 1, 2013, 00:00

  • Variation in Treatment Patterns and Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Across European Countries

    Nov 1, 2013, 00:00

  • User Preferences for Stroke Services in Wales

    Nov 1, 2013, 00:00

  • Methodological Challenges of Cost-Of-Illness Studies on Dementia- An International Systematic Review

    Nov 1, 2013, 00:00

  • Validation of the French Translated Version of the Osteoporosis Specific Morisky Medication Adherence Scale (OS-MMAS) in France

    Nov 1, 2013, 00:00

  • Ações De Farmacovigilância- Relato De Notificações De Medicamentos À Agência Nacional De Vigilância Sanitária (ANVISA) – Brasil

    Nov 1, 2013, 00:00

  • Diminishing Marginal Disutility of Hypoglycaemic Events

    Nov 1, 2013, 00:00

  • The Analysis of Costs and Reimbursements for Lung Cancer Treatment in the Czech Republic

    Nov 1, 2013, 00:00

  • Interim Results from the Burden of Bowel Dysfunction in Spinal Cord Injury Study

    Nov 1, 2013, 00:00

  • Are ICER Threshold Values Malleable? The Case of Life-Extending Cancer Treatments at the End of Life

    Nov 1, 2013, 00:00

  • Argentinian Survey in Cost of Illness and Unmet Needs in Multiple Sclerosis- Treatment Experience the Costs of MS Patients in Argentina

    Nov 1, 2013, 00:00

  • Cost Assessment of Metastatic and Non-Metastatic Castration-Resistant Prostate Cancer Patient-Management in Spain

    Nov 1, 2013, 00:00

  • Glycemic, Lipid, and Blood Pressure Control Among Type 2 Diabetes Mellitus Patients in Dubai

    Nov 1, 2013, 00:00

  • The Effect of Positive Margins on Outcomes in Breast Cancer

    Nov 1, 2013, 00:00

  • Impact of Major Clinical Events on Utilities in the Context of Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) Treated with Dialysis

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Linaclotide in the Treatment of Irritable Bowel Syndrome with Constipation in Belgium

    Nov 1, 2013, 00:00

  • Cost Effectiveness Analysis of Boceprevir (BOC) Added to Pegifn/Ribavirin (P/R) Versus Pegifn/Ribavirin (Current Standard of Care) for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Greece

    Nov 1, 2013, 00:00

  • Remote Patient Monitoring in CRT-D Recipients May Reduce Use of Hospital-Based Care

    Nov 1, 2013, 00:00

  • Impact of the German Amnog Evaluation on Drug Prices- Correlation of Rebate?

    Nov 1, 2013, 00:00

  • Hepatitis C Virus Infection Treatment Completion- An Analysis of the Quebec Provincial Reimbursement Program Database

    Nov 1, 2013, 00:00

  • The Burden of Untreated Patients Experiencing Symptoms of Overactive Bladder

    Nov 1, 2013, 00:00

  • Technical Errors in Cost-Effectiveness Models- Evidence from the Single Technology Appraisal Programme in England and Wales

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life of Hemodialysis Patients in Indonesia

    Nov 1, 2013, 00:00

  • Essential Medicine List (Cuadro Básico) in México. Is It a Guideline for Decision Making on the Current and Future Health Needs?

    Nov 1, 2013, 00:00

  • HR-QOL Data in the Amnog Early Benefit Assessment- Industry and IQWIG/GBA Perspective

    Nov 1, 2013, 00:00

  • Budget Impact Analisis of Switching from DPT and Monovalent Vaccines to DTaP–IPV-Hib Combined Vaccine into Russian Immunization Schedule

    Nov 1, 2013, 00:00

  • Cost-Utility of Apixaban Compared to Warfarin for Stroke Prevention in Patients with Atrial Fibrillation in Colombia

    Nov 1, 2013, 00:00

  • Trastuzumabe Para Câncer De Mama Com Superexpressão De HER-2- Evidência De Eficácia, Segurança E Estimativa De Custo

    Nov 1, 2013, 00:00

  • Proxy Utility Assessment in Acute Heart Failure

    Nov 1, 2013, 00:00

  • Diagnosis of Pancreatic Exocrine Insufficiency in Chronic Pancreatitis, Pancreatic Cancer and Gastrointestinal or Pancreatic Surgery Patients- A Systematic Literature Review and Expert Consensus on the Accuracy of Diagnostic Test Used in Sp ...

    Nov 1, 2013, 00:00

  • Treatment Patterns and Health Care Resource Utilization of Patients with Acromegaly in the United States

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life and Utility in Patients with Diabetic Foot Syndrome - An EQ-5D Survey in Poland

    Nov 1, 2013, 00:00

  • Which Should Be the Correct NMA to Be Used? A Review of HTA Recommendations

    Nov 1, 2013, 00:00

  • Evaluating Overall Survival in Oncology Trials with Subsequent Therapies- A Methodological Review and Application in Non-Small Cell Lung Cancer

    Nov 1, 2013, 00:00

  • Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with Insulin

    Nov 1, 2013, 00:00

  • Modeling the Cardiovascular Effects of Switching Patients from Rosuvastatin to Atorvastatin

    Nov 1, 2013, 00:00

  • Generic Substitution in Ireland – The Views of Key Stakeholders

    Nov 1, 2013, 00:00

  • EU Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement Decisions

    Nov 1, 2013, 00:00

  • The Relationship Between Asthma-Specific Quality of Life and Measures of Asthma Control and Generic Quality of Life

    Nov 1, 2013, 00:00

  • Comparison of Disease Status, Treatments and Outcomes of Patients with Psoriatic Arthritis Receiving Their First Biologic in the European Union and United States

    Nov 1, 2013, 00:00

  • The Impact of Commodities and Extra-Articular Manifestations in Rheumatoid Arthritis Patients

    Nov 1, 2013, 00:00

  • Decision Making in HIRA for 5 Years of Positive List System

    Nov 1, 2013, 00:00

  • Using Rasch Analysis to Co-Calibrate Scores from Outcome Measures Specific to Asthma (ALIS), Chronic Obstructive Pulmonary Disease (LCOPD) and Pulmonary Hypertension (CAMPHOR)

    Nov 1, 2013, 00:00

  • Ruling Out IBD in the United Kingdom and Brazil- Is the Usage of F-Calprotectin in Primary Care Cost-Effective?

    Nov 1, 2013, 00:00

  • Health Transformation Program Impact on Import and Local Pharmaceutical Consumption in Turkey

    Nov 1, 2013, 00:00

  • Characterizing Disease Burden in an Ultra-Rare Disease in the United States- Transthyretin (TTR) Amyloidosis Patients Caregivers

    Nov 1, 2013, 00:00

  • Defining Eligible Patient Population in São Paulo State Based on Cleopatra Trial Inclusion Criteria- A Retrospective Analysis of Fundação Oncocentro (FOSP) Cancer Patient Registry (Registro Hospitalar Do Câncer – RHC)

    Nov 1, 2013, 00:00

  • Patient-Reported Outcome (PRO) Claims in Products Approved for Chronic Obstructive Pulmonary Diseases (COPD) in Europe and the United States

    Nov 1, 2013, 00:00

  • Estimated Osteoporotic Population and the Related Medication Consumption in Municipality Level – Discrepancies Observed Through Data Visualization Approach

    Nov 1, 2013, 00:00

  • Pathological Gambling- A Growing Addiction

    Nov 1, 2013, 00:00

  • Persistence with Medications- A Discrete Choice Experiment of Preferences Among Hypertensive Patients

    Nov 1, 2013, 00:00

  • Methodology for Establishing Internal and External Validity When Propensity Score Matching Is Used

    Nov 1, 2013, 00:00

  • The Burden of Clostridium Difficile in Spain- A Retrospective Matched-Cohort Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery

    Nov 1, 2013, 00:00

  • EQ-5D Utility Weights Associated with Response to Treatment with Matrix Applied Autologous Cultured Chondrocytes (MACI) Implant and Microfracture for Cartilage Defects of the Knee

    Nov 1, 2013, 00:00

  • Dynamic Modeling of Vector-Borne Diseases (VBD)- The Example of Malaria

    Nov 1, 2013, 00:00

  • The Annual Treatment and Rehabillitation Costs of Patients with Paraplegia in the Private Health Care Setting in Greece

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Asenapine Versus Atypical Antipsychotics Used in Turkey in the Treatment of Bipolar I Disorder

    Nov 1, 2013, 00:00

  • Modelling the Health Technology Assessment (HTA) Process for Innovative Drug Technologies (IDTS) in the Turkish Health Care System

    Nov 1, 2013, 00:00

  • Screening Characteristics and Diabetes Biomarkers in French and UK Patient-Level Databases

    Nov 1, 2013, 00:00

  • Impact of Short Periods with Improved or Worsened INR Control on Life Expectancy and QALYs in Patients with Atrial Fibrillation

    Nov 1, 2013, 00:00

  • Assessing the Burden of Caregiving for Patients with Lung Cancer in Europe

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Asenapine Versus Atypical Antipsychotics Used in Turkey in the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • The Health of Health Technology Assessment in Ireland- Five Points for Improvement

    Nov 1, 2013, 00:00

  • Study of Quality of Life and Costs for CML Patients in Bulgaria

    Nov 1, 2013, 00:00

  • A Systematic Review of Economic Evidence in Hepatitis C- Methods Used in Recent Economic Evaluations

    Nov 1, 2013, 00:00

  • Costs of HER 2 Negative, Hormonal Receptor Positive, Metastatic Breast Cancer (MBC-HR+) Treated with Everolimus (EVE) + Exemestane (EXE) in the Brazilian Private System (BPS)- A Real World (RW) and Published Literature Analysis

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life in Patients Along First Year Poststroke in Spain

    Nov 1, 2013, 00:00

  • The Role of DSM in the EMA and FDA Authorization Process for Psychiatric Drugs

    Nov 1, 2013, 00:00

  • Study of Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Symptom Assessment Differences Between Patients and Family Members

    Nov 1, 2013, 00:00

  • In-Hospital and Long-Term Mortality and Morbidity Burdens in Patients with Acute Coronary Syndromes

    Nov 1, 2013, 00:00

  • Análisis De Minimización De Costos De Iobitridol Versus Otros Medios De Contraste Iodados Iso E Hipo-Osmolales En Población General

    Nov 1, 2013, 00:00

  • Evaluation of the Burden of Illness of Skin Cancer Among Veteran Patients United States

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Direct Medical Costs Among Patients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Los Profesionales De Enfermeria Con Experiencia Laboral En Uci Versus Sin Experiencia Laboral En El Error De La Medicación Parenteral En Pacientes Adultos Hospitalizados En Uci

    Nov 1, 2013, 00:00

  • Pharmaceutical Regulation in Europe and Its Impact on Corporate RD

    Nov 1, 2013, 00:00

  • Impact of Reimbursement of Medicines on Economic Accessibility Level for Working Population in Republic of Moldova

    Nov 1, 2013, 00:00

  • Wellbeing, Life Satisfaction and Progression in Alzheimer’s Disease – An Alsova Follow-Up Study

    Nov 1, 2013, 00:00

  • Validation of Disease States in Schizophrenia- Comparison of Cluster Analysis Between the United States and European Populations

    Nov 1, 2013, 00:00

  • Agreement Between Child and Parent Symptom Diary Responses in Chronic Constipation (CC) and Irritable Bowel Syndrome with Constipation (IBS-C)- Implications for the Measurement of Symptoms in Young Children

    Nov 1, 2013, 00:00

  • Adherence by Spanish Retinologists to the Guidance for the Management of Patients with Wet Age-Related Macular Degeneration

    Nov 1, 2013, 00:00

  • The Impact of Memory Problems on Diabetes Treatment in the United Kingdom

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Tocilizumab in Combination with Methotrexate Versus Standard of Care for the Treatment of Rheumatoid Arthritis in Greece

    Nov 1, 2013, 00:00

  • Who Knows Better? A Knowledge, Attitude and Practice Survey of Osteoporosis Prescreening Tools Among Pharmacists and Physicians

    Nov 1, 2013, 00:00

  • Antibacterial Treatment of Meticillin-Resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections- A Cost-Effectiveness Analysis in Greece

    Nov 1, 2013, 00:00

  • The Expected Health Economic Value of Using Circulating Tumor Cells to Personalize Cancer Treatment

    Nov 1, 2013, 00:00

  • Use of the Clinical Practice Research Datalink (CPRD) to Assess ‘Real-World’ Management of Tuberous Sclerosis Complex (TSC) in the United Kingdom

    Nov 1, 2013, 00:00

  • Patients at the Center of Regulatory Decisions- Using Stated-Preference Data to Help Regulators Answer Difficult Questions

    Nov 1, 2013, 00:00

  • Characteristics of Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Inhaled Corticosteroid/Long-Acting b2-ß2-agonist (ICS/LABA) Fixed Combination Products in English Primary Care

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad Del Tratamiento Farmacológico Para Las Manifestaciones Clínicas Mucocutáneas De La Enfermedad De Behcet

    Nov 1, 2013, 00:00

  • Estimating Chronic Disease PREVALENCE from Claims Data- Reducing Bias by Accounting for Diseased Individuals Who Do Not Generate Claims

    Nov 1, 2013, 00:00

  • Assessing the Significance of HbA1c Durability in Cost Effectiveness Analysis of 2nd Line Oral Therapies in the Management of Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Costo E Impacto Presupuestal Del Tratamiento De La Artritis Reumatoide Moderada Y Severa Considerando El Uso De Terapias Biológicas En México

    Nov 1, 2013, 00:00

  • Disponibilidad Y Fuentes De La Información Para La Toma De Decisiones En Reumatología- Uso De Los Estudios Económicos

    Nov 1, 2013, 00:00

  • Exploring the Key Decision Drivers Provided by HTA Agencies Rejecting Submissions with ICERs Lower Than the Threshold

    Nov 1, 2013, 00:00

  • Linezolid for the Treatment of Patients with Confirmed MRSA Nosocomial Pneumonia in Nanjing, China- A Cost Effective Alternative to Vancomycin

    Nov 1, 2013, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108 (current)
  • 109
  • 110
  • »